跳至主要内容
临床试验/TCTR20230428001
TCTR20230428001进行中(未招募)4 期

A prospective, double-blinded, randomized controlled trial to evaluate the efficacy of intravenous nefopam on postoperative opioid consumption after laparoscopic liver surgery

Khon Kaen University0 个研究点目标入组 104 人开始时间: 2023年4月28日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
入组人数
104

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • 1. Age 18-65 years old
  • 2. Patient who undergoing laparoscopic liver surgery
  • 3. ASA classification I-III

排除标准

  • 1. Severe systemic medical condition such as poor-controlled hypertension, heart disease, lung disease, renal dysfunction with GFR less than 60, poor-controlled diabetes mellitus, Child-Pugh class B or C, Abnormal liver function test (total bilirubin > 2 mg/dL, INR > 1.7, albumin < 3,5 g/dL, or aspartate or alanine aminotransferase > 2 times of upper limit of normal), neuromuscular disease
  • 2. Chronic pain problem
  • 3. Prescribed analgesic drugs
  • 4. Contraindication to nefopam such as tachyarrhythmia, pregnancy, convulsive disorder, taking monoamine oxidase inhibitors
  • 5. Allergic to study drugs
  • 6. Unable or refusal to use IV PCA
  • 7. Unable to understand and report numeric rating pain score
  • 8. Anesthetic care personnel plan to do neuraxial or trunk blocks

研究者

相似试验

A prospective, double-blinded, randomized controlled... | 临床试验